Want to join the conversation?
Karl Keirstead of Deutsche Bank asks about the pipeline and outlook for 4Q17. $CRM said it feels strongly about the pipeline going into 2H17. The level of engagement is very strong and the pipeline is good. The FX sequential headwind to deferred revenue seen in 2Q17 is factored into the overall plan along with the compounded effect of invoicing.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?